M-M-R®II

BIOLOGICAL3 trials

Sponsors

GlaxoSmithKline, Merck Sharp & Dohme LLC

Conditions

Haemophilus Influenzae Type bHepatitis ANeisseria MeningitidisPneumococcal Infections

Phase 2

Hib-MenCY-TT Vaccine Study Compared to Licensed Hib and Meningococcal Serogroup C Conjugate Vaccines

CompletedNCT00134719

GlaxoSmithKlineHaemophilus Influenzae Type b, Neisseria Meningitidis

Start: 2005-04-11End: 2007-02-21Updated: 2018-07-19

Phase 3

Immunogenicity & Safety of Hepatitis A Vaccine Co-admin With a Measles/Mumps/Rubella & a Varicella Vaccine in Children

CompletedNCT00197015

GlaxoSmithKlineHepatitis A

Start: 2003-10-06End: 2009-06-09Updated: 2018-07-31

Safety, Tolerability, and Immunogenicity of a 3-dose Regimen of V114 in Healthy Infants (PNEU-PED-EU-2/V114-026)

CompletedNCT04016714

Merck Sharp & Dohme LLCPneumococcal Infections

Start: 2019-08-28End: 2021-10-29Updated: 2023-05-06

Related Papers

Immunogenicity and safety of measles-mumps-rubella and varicella vaccines coadministered with a fourth dose of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine in toddlers: a pooled analysis of randomized trials.

2012-08-017 citations